COVID-19 in 2021: Is it the major disrupter that eHealth needs?

Aust J Gen Pract. 2021 Feb 15:50. doi: 10.31128/AJGP-COVID-47.

Author

Deborah Claire Saltman¹

Affiliation

¹ AM, PhD, MD, Chairman, Independent Advisory Steering Committee, Medicines @ Healthcare products, Regulatory Agency, UK; Visiting Professor, Imperial College, UK.

PMID: 34781322
DOI: 10.31128/AJGP-COVID-47

Abstract

COVID-19 has precipitated a new range of activities, including expanding the content, context and funding of telehealth.

MeSH terms

COVID-19*
Humans
SARS-CoV-2
Telemedicine*